Katelyn A Bruno

Katelyn A Bruno, PhD, FHFSA

Assistant Professor Of Cardiovascular Medicine

Business Phone: (352) 273-9064
Business Email: katelyn.bruno@ufl.edu

About Katelyn A Bruno

Dr. Katelyn Bruno is an Assistant Professor of Cardiovascular Medicine in the Department of Medicine/Division of Cardiovascular Medicine with joint appointments in the Department of Physiology and Aging and the Center of Regenerative Medicine. She received her Ph.D. in Environmental Health Sciences with a focus on Molecular and Translational Toxicology from Johns Hopkins Bloomberg School of Public Health in 2016 and completed her Postdoctoral Fellowship at Mayo Clinic in Jacksonville, Florida. Her broad focus includes translational science, cardiology, immunology, toxicology and sex differences. Dr. Bruno is actively involved in organizational and scientific organizations including serving as faculty advisor for the UF RegeneGators student organization and holding committee and leadership roles for societies such as HFSA, FCACC, OSSD and ISCMF.

Additional Positions:
Research Collaborator
2022 – Current · Mayo Clinic
Courtesy Research Faculty
2020 – Current · University of North Florida
Related Links:


Fellow, Heart Failure Society of America (FHFSA)
2022 · Heart Failure Society of America
Special Achievement Award
2022 · Florida Chapter of the American College of Cardiology
2020 Outstanding Quality Improvement Project, Gold Zebra EDS Clinic
2021 · Mayo Clinic
Selected Menttee
2021 · European Society of Cardiology Heart Failure Association Translational Winter Meeting
Team Science Award Recognition
2021 · Mayo Clinic
Biology of Sex Differences Journal Selection of Best Poster Prize Finalist
2019 · Organization for the Study of Sex Differences Meeting
Future Leader in Heart Failure Designation
2019 · Heart Failure Society of America
Heart Failure Specialists of Tomorrow (HOT) Travel Award
2019 · Heart Failure Association of the European Society of Cardiology
Travel Award to Heart Failure Association of the European Society of Cardiology Meeting, Athens, Greece
2019 · Heart Failure Association of the European Society of Cardioloy
Young Investigator of the Year Award: Basic and Translational Science
2019 · Heart Failure 2019 & World Congress on Acute Heart Failure, Heart Failure Association of the European Society of Cardiology
Above & Beyond Certificate of Excellence
2018 · Mayo Clinic
Environmental Scholar
2018 · American Pediatric Association (APA)
Heart Failure Specialists of Tomorrow (HOT) Travel Award
2018 · Heart Failure Association of the European Society of Cardiology
New Investigator Travel Award
2018 · American Heart Association: Basic Cardiovascular Sciences Scientific Sessions (BCVS)
The Jay N. Cohn New Investigator Award Runner-Up
2018 · Heart Failure Society of America
Young Investigator Award
2016 · Mayo Clinic Angiogenesis and Tumor Microenvironment Symposium
Poster Award
2014 · American Association of Immunologist Annual Meeting
1st Place Poster Presentation
2013 · What a Difference an X Makes Conference hosted by Society of Women’s Health Research

Teaching Profile

Courses Taught
IDH3931 Interdisciplinary Junior Honors

Research Profile

Dr. Bruno’s graduate research focused on the mechanisms of hormones and endocrine disruptors in myocarditis (inflammatory heart disease). Dr. Bruno continued studying myocarditis during her postdoctoral fellowship focusing on new diagnostics (biomarkers and imaging) and therapeutics for acute myocarditis and dilated cardiomyopathy. Dr. Bruno is experienced in basic and translational research working with cell culture, animals and patients samples. In addition to her role as a NIAID funded tenure track Assistant Professor studying novel models and mechanisms of both pediatric and adult myocarditis, Dr. Bruno is also Co-Investigator on several internally funded grants and a DoD grant. Dr. Bruno has volunteer roles in several healthcare based non-profits in order to personally connect with the people who are affected by myocarditis and is involved in leadership for several scientific organizations.

Open Researcher and Contributor ID (ORCID)


Areas of Interest
  • Cardio-Oncology
  • Dilated Cardiomyopathy
  • Heart Failure
  • Myocarditis
  • Sex Differences


Extracellular vesicles as personalized medicine.
Molecular aspects of medicine. 91 [DOI] 10.1016/j.mam.2022.101155. [PMID] 36456416.
High overlap in patients diagnosed with hypermobile Ehlers-Danlos syndrome or hypermobile spectrum disorders with fibromyalgia and 40 self-reported symptoms and comorbidities.
Frontiers in medicine. 10 [DOI] 10.3389/fmed.2023.1096180. [PMID] 37181352.
Laryngological Complaint Prevalence in Hypermobile Ehlers-Danlos or Hypermobility Spectrum Disorders.
The Laryngoscope. [DOI] 10.1002/lary.30964. [PMID] 37597175.
Rates Among Hospitalized Patients With COVID-19 Treated With Convalescent Plasma: A Systematic Review and Meta-Analysis.
Mayo Clinic proceedings. Innovations, quality & outcomes. 7(5):499-513 [DOI] 10.1016/j.mayocpiqo.2023.09.001. [PMID] 37859995.
Reconstituted Extracellular Vesicles from Human Platelets Decrease Viral Myocarditis in Mice
Small. [DOI] 10.1002/smll.202303317.
Sex and gender differences in myocarditis and dilated cardiomyopathy: An update.
Frontiers in cardiovascular medicine. 10 [DOI] 10.3389/fcvm.2023.1129348. [PMID] 36937911.
The Impact of a Group Telemedicine Program for Chronic Disease: A Retrospective Cohort Survey Study on Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorder
Telemedicine and e-Health. 29(2):261-269 [DOI] 10.1089/tmj.2022.0092.
Cardiovascular Factors Associated with COVID-19 from an International Registry of Primarily Japanese Patients.
Diagnostics (Basel, Switzerland). 12(10) [DOI] 10.3390/diagnostics12102350. [PMID] 36292038.
Chapter 9. Autoimmune Heart Disease
Translational Autoimmunity: Autoimmune Diseases in Different Organs, Part IV: Specific Autoimmune Diseases.
Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19
Nature Medicine. 28(1):51-52 [DOI] 10.1038/s41591-021-01638-6.
Establishing an Ehlers-Danlos Syndrome Clinic: Lessons Learned.
SN comprehensive clinical medicine. 4(1) [DOI] 10.1007/s42399-022-01218-w. [PMID] 35811641.
Late Treatment for COVID-19 With Convalescent Plasma
CHEST. 162(5):e283-e284 [DOI] 10.1016/j.chest.2022.07.029. [PMID] 36344142.
Molecular Modeling and Phenotypic Description of a Patient with a Novel Exonic Deletion of GALNS with Resultant Morquio Syndrome with Two Successful Pregnancies
Molecular Syndromology. 13(4):1-8 [DOI] 10.1159/000519326. [PMID] 36158053.
Myocarditis and Pericarditis
Comprehensive Pharmacology. 413-431 [DOI] 10.1016/b978-0-12-820472-6.00091-8.
Sex and age differences in sST2 in cardiovascular disease.
Frontiers in cardiovascular medicine. 9 [DOI] 10.3389/fcvm.2022.1073814. [PMID] 36741845.
Sex differences in comorbidities associated with Sjögren’s disease.
Frontiers in medicine. 9 [DOI] 10.3389/fmed.2022.958670. [PMID] 35991633.
Upregulation of Endothelin-1 May Predict Chemotherapy-Induced Cardiotoxicity in Women with Breast Cancer
Journal of Clinical Medicine. 11(12) [DOI] 10.3390/jcm11123547. [PMID] 35743613.
A Novel Circulating MicroRNA for the Detection of Acute Myocarditis.
The New England journal of medicine. 384(21):2014-2027 [DOI] 10.1056/NEJMoa2003608. [PMID] 34042389.
Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study
PLOS Medicine. 18(12) [DOI] 10.1371/journal.pmed.1003872. [PMID] 34928960.
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19.
The New England journal of medicine. 384(11):1015-1027 [DOI] 10.1056/NEJMoa2031893. [PMID] 33523609.
Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence
SSRN Electronic Journal. [DOI] 10.2139/ssrn.1116056.
Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence.
Frontiers in medicine. 8 [DOI] 10.3389/fmed.2021.684151. [PMID] 34164419.
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors
Nature Communications. 12(1) [DOI] 10.1038/s41467-021-25113-5. [PMID] 34381030.
Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasma.
medRxiv : the preprint server for health sciences. [DOI] 10.1101/2021.04.08.21255115. [PMID] 33851175.
Sex Differences, Genetic and Environmental Influences on Dilated Cardiomyopathy
Journal of Clinical Medicine. 10(11) [DOI] 10.3390/jcm10112289. [PMID] 34070351.
Sex-Specific Effects of Plastic Caging in Murine Viral Myocarditis
International Journal of Molecular Sciences. 22(16) [DOI] 10.3390/ijms22168834. [PMID] 34445539.
The Effect of Convalescent Plasma Therapy on COVID-19 Patient Mortality: Systematic Review and Meta-analysis.
medRxiv : the preprint server for health sciences. [DOI] 10.1101/2020.07.29.20162917. [PMID] 33140056.
The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis.
Mayo Clinic proceedings. 96(5):1262-1275 [DOI] 10.1016/j.mayocp.2021.02.008. [PMID] 33958057.
The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated with Convalescent Plasma.
medRxiv : the preprint server for health sciences. [DOI] 10.1101/2021.01.19.21249678. [PMID] 33501470.
The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated With Convalescent Plasma.
Frontiers in medicine. 8 [DOI] 10.3389/fmed.2021.707895. [PMID] 35155458.
Trpc6 Promotes Doxorubicin-Induced Cardiomyopathy in Male Mice With Pleiotropic Differences Between Males and Females.
Frontiers in cardiovascular medicine. 8 [DOI] 10.3389/fcvm.2021.757784. [PMID] 35096991.
Use of convalescent plasma in COVID-19 patients with immunosuppression.
Transfusion. 61(8):2503-2511 [DOI] 10.1111/trf.16525. [PMID] 34036587.
Association of Genetic Variants at TRPC6 With Chemotherapy-Related Heart Failure.
Frontiers in cardiovascular medicine. 7 [DOI] 10.3389/fcvm.2020.00142. [PMID] 32903434.
Autoimmune Myocarditis: Animal Models
Myocarditis. 111-127 [DOI] 10.1007/978-3-030-35276-9_6.
Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients.
medRxiv : the preprint server for health sciences. [DOI] 10.1101/2020.05.12.20099879. [PMID] 32511566.
Early safety indicators of COVID-19 convalescent plasma in 5000 patients
Journal of Clinical Investigation. 130(9):4791-4797 [DOI] 10.1172/jci140200.
Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience.
medRxiv : the preprint server for health sciences. [DOI] 10.1101/2020.08.12.20169359. [PMID] 32817978.
Examination of Molecular Effects of MYLK Deletion in a Patient with Extensive Aortic, Carotid, and Abdominal Dissections That Underlie the Genetic Dysfunction.
Case reports in medicine. 2020 [DOI] 10.1155/2020/5108052. [PMID] 32655646.
Myoglobin for Detection of High-Risk Patients with Acute Myocarditis.
Journal of cardiovascular translational research. 13(5):853-863 [DOI] 10.1007/s12265-020-09957-8. [PMID] 32006209.
Safety Update
Mayo Clinic Proceedings. 95(9):1888-1897 [DOI] 10.1016/j.mayocp.2020.06.028. [PMID] 32861333.
Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity.
Nature communications. 11(1) [DOI] 10.1038/s41467-020-15129-8. [PMID] 32198351.
BPA Alters Estrogen Receptor Expression in the Heart After Viral Infection Activating Cardiac Mast Cells and T Cells Leading to Perimyocarditis and Fibrosis.
Frontiers in endocrinology. 10 [DOI] 10.3389/fendo.2019.00598. [PMID] 31551929.
Elevated Sera sST2 Is Associated With Heart Failure in Men ≤50 Years Old With Myocarditis.
Journal of the American Heart Association. 8(2) [DOI] 10.1161/JAHA.118.008968. [PMID] 30638108.
Sex differences in pulmonary arterial hypertension: role of infection and autoimmunity in the pathogenesis of disease.
Biology of sex differences. 9(1) [DOI] 10.1186/s13293-018-0176-8. [PMID] 29669571.
Type 1 sialidosis presenting with ataxia, seizures and myoclonus with no visual involvement.
Molecular genetics and metabolism reports. 15:11-14 [DOI] 10.1016/j.ymgmr.2017.12.005. [PMID] 30023283.
Genome-wide association study of cardiotoxicity in the NCCTG N9831 (Alliance) adjuvant trastuzumab trial.
Pharmacogenetics and genomics. 27(10):378-385 [DOI] 10.1097/FPC.0000000000000302. [PMID] 28763429.
Sex Determines Cardiac Myocyte Stretch and Relaxation.
Circulation. Cardiovascular genetics. 10(5) [DOI] 10.1161/CIRCGENETICS.117.001950. [PMID] 29030406.
LC-MS/MS analysis of 2-aminothiazoline-4-carboxylic acid as a forensic biomarker for cyanide poisoning.
World journal of methodology. 2(5):33-41 [DOI] 10.5662/wjm.v2.i5.33. [PMID] 25237615.
Update on coxsackievirus B3 myocarditis.
Current opinion in rheumatology. 24(4):401-7 [DOI] 10.1097/BOR.0b013e328353372d. [PMID] 22488075.


Jul 2023 ACTIVE
Sex differences in novel viral myocarditis therapeutic: adipose-derived stem cell secretome
Role: Principal Investigator
Dec 2022 ACTIVE
Vitamin D binding protein (DBP) in innate immune cell response in viral myocarditis
Role: Principal Investigator


Postdoctoral Fellowship
2016-2021 · Mayo Clinic
Doctor of Philosophy (PhD)
2011-2016 · Johns Hopkins School of Public Health
BS in Chemistry (Minor in Biology)
2010-2011 · Sam Houston State University
BS in Criminal Justice (Minor in Chemistry)
2007-2010 · Sam Houston State University

Contact Details

(352) 273-9064
Administrative Spec I:
Business Street:
P.O. Box 100288
Division of Cardiovascular Medicine